GLCGX
Price
$34.39
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
RGAHX
Price
$80.30
Change
-$0.73 (-0.90%)
Updated
Nov 14 closing price
Ad is loading...

GLCGX vs RGAHX

Header iconGLCGX vs RGAHX Comparison
Open Charts GLCGX vs RGAHXBanner chart's image
Goldman Sachs Large Cap Gr Insghts A
Price$34.39
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$80.30
Change-$0.73 (-0.90%)
VolumeN/A
CapitalizationN/A
GLCGX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GLCGX vs. RGAHX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCGX is a Buy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 306B vs. GLCGX (1.41B). RGAHX pays higher dividends than GLCGX: RGAHX (0.64) vs GLCGX (0.00). GLCGX was incepted earlier than RGAHX: GLCGX (28 years) vs RGAHX (9 years). GLCGX is a more actively managed with annual turnover of: 206.00 vs. RGAHX (31.00). RGAHX has a lower initial minimum investment than GLCGX: RGAHX (250) vs GLCGX (1000). GLCGX (32.28) and RGAHX (31.44) have marching annual gain over last year. RGAHX return over 5 years is better than : 57.44 vs. GLCGX (6.55).
GLCGXRGAHXGLCGX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years9 years-
Gain YTD34.82229.960116%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.41B306B0%
Annual Yield % from dividends0.000.64-
Returns for 1 year32.2831.44103%
Returns for 3 years-30.43-1.172,595%
Returns for 5 years6.5557.4411%
Returns for 10 years60.64N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARE109.030.70
+0.65%
Alexandria Real Estate Equities
PK15.110.02
+0.13%
Park Hotels & Resorts
PX11.80-0.28
-2.32%
P10
INZY3.55-0.21
-5.59%
Inozyme Pharma
BCTX0.60-0.05
-7.75%
BriaCell Therapeutics Corp